» Articles » PMID: 25590678

Updated Estimates of Neural Tube Defects Prevented by Mandatory Folic Acid Fortification - United States, 1995-2011

Overview
Date 2015 Jan 16
PMID 25590678
Citations 178
Authors
Affiliations
Soon will be listed here.
Abstract

In 1992, the U.S. Public Health Service recommended that all women capable of becoming pregnant consume 400 µg of folic acid daily to prevent neural tube defects (NTDs). NTDs are major birth defects of the brain and spine that occur early in pregnancy as a result of improper closure of the embryonic neural tube, which can lead to death or varying degrees of disability. The two most common NTDs are anencephaly and spina bifida. Beginning in 1998, the United States mandated fortification of enriched cereal grain products with 140 µg of folic acid per 100 g. Immediately after mandatory fortification, the birth prevalence of NTD cases declined. Fortification was estimated to avert approximately 1,000 NTD-affected pregnancies annually. To provide updated estimates of the birth prevalence of NTDs in the period after introduction of mandatory folic acid fortification (i.e., the post-fortification period), data from 19 population-based birth defects surveillance programs in the United States, covering the years 1999-2011, were examined. After the initial decrease, NTD birth prevalence during the post-fortification period has remained relatively stable. The number of births occurring annually without NTDs that would otherwise have been affected is approximately 1,326 (95% confidence interval = 1,122-1,531). Mandatory folic acid fortification remains an effective public health intervention. There remain opportunities for prevention among women with lower folic acid intakes, especially among Hispanic women, to further reduce the prevalence of NTDs in the United States.

Citing Articles

Biological, dietetic and pharmacological properties of vitamin B.

Siatka T, Matus M, Moravcova M, Harcarova P, Lomozova Z, Matousova K NPJ Sci Food. 2025; 9(1):30.

PMID: 40075081 PMC: 11904035. DOI: 10.1038/s41538-025-00396-w.


Evolving Insights into Prickle2 in Neurodevelopment and Neurological Disorders.

Yang Y, Mao Y, Zhang Y, Xiong T Mol Neurobiol. 2025; .

PMID: 40009262 DOI: 10.1007/s12035-025-04795-8.


The Expression of Alpha-Fetoprotein in Human Blastocoel Fluid-Conditioned Media In Vitro: A Proof of Concept Study.

Kavoussi S, Chen S, Wininger J, Lal A, Roudebush W, Kavoussi P Int J Mol Sci. 2025; 26(4).

PMID: 40004185 PMC: 11855035. DOI: 10.3390/ijms26041722.


Folate and Vitamin B12 Status among Non-Pregnant, Non-Lactating Women of Reproductive Age and Predicted Risk for Neural Tube Defects, Morogoro Region, Tanzania.

Mai C, Long K, Lukindo T, Jabbar S, Gwakisa J, Rosenthal J Matern Child Health J. 2025; .

PMID: 39847253 DOI: 10.1007/s10995-025-04046-1.


A Randomized Crossover Trial of Acceptability of Quadruple-Fortified Salt in Women and their Households in Southern India.

Guetterman H, Rajagopalan K, Fox A, Johnson C, Fothergill A, George N J Nutr. 2024; 155(1):322-337.

PMID: 39490799 PMC: 11795687. DOI: 10.1016/j.tjnut.2024.10.037.


References
1.
Pfeiffer C, Hughes J, Lacher D, Bailey R, Berry R, Zhang M . Estimation of trends in serum and RBC folate in the U.S. population from pre- to postfortification using assay-adjusted data from the NHANES 1988-2010. J Nutr. 2012; 142(5):886-93. PMC: 3327747. DOI: 10.3945/jn.111.156919. View

2.
Crider K, Zhu J, Hao L, Yang Q, Yang T, Gindler J . MTHFR 677C->T genotype is associated with folate and homocysteine concentrations in a large, population-based, double-blind trial of folic acid supplementation. Am J Clin Nutr. 2011; 93(6):1365-72. DOI: 10.3945/ajcn.110.004671. View

3.
. Spina bifida and anencephaly before and after folic acid mandate--United States, 1995-1996 and 1999-2000. MMWR Morb Mortal Wkly Rep. 2004; 53(17):362-5. View

4.
Tinker S, Cogswell M, Devine O, Berry R . Folic acid intake among U.S. women aged 15-44 years, National Health and Nutrition Examination Survey, 2003-2006. Am J Prev Med. 2010; 38(5):534-42. DOI: 10.1016/j.amepre.2010.01.025. View

5.
Crider K, Devine O, Hao L, Dowling N, Li S, Molloy A . Population red blood cell folate concentrations for prevention of neural tube defects: Bayesian model. BMJ. 2014; 349:g4554. PMC: 4115151. DOI: 10.1136/bmj.g4554. View